Separate names with a comma.
What's the reason for Celgene going down even after beating the estimates and lifting 2018 outlook? Any thoughts?...
Eli Lilly reports an increase in pharma sales and decline in Animal Health. Lifts 2018 earnings outlook. When answering an analyst question,...
http://alph.st/ba1df6ff Higher sales of Revlimid and Otezla help Celgene to report better than expected sales figure. Will the two (Impact and...
When providing the outlook for 2018, Saunders said that Allergan faces LOE losses in 2018. But still it has got good long-term prospects. Saunders...
After raising the quarterly dividend recently, Lilly has provided outlook for 2018 and expects recently launched products to drive revenue. Dave...